Acadia Healthcare Company Inc. is a publicly traded provider of specialty behavioral health services in the United States, founded in 1987 and headquartered in Franklin, Tennessee, United States. The company operates over 180 facilities that deliver inpatient psychiatric care, residential addiction treatment, and outpatient mental health services. Under Interim CEO Kevin Truitt, Acadia emphasizes integrated treatment models and digital health innovations. This diversified approach positions the company to effectively navigate regulatory pressures and capitalize on growth opportunities in the evolving healthcare market.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
3,312,770
3,153,960
2,928,740
2,610,400
Gross Profit
3,312,770
3,153,960
2,928,740
2,610,400
Selling, General & Administrative Expenses
2,064,200
1,928,590
1,794,900
1,596,910
Depreciation & Amortization Expenses
189,249
149,595
132,349
117,769
Other Operating Expenses
1,993,840
617,530
960,895
473,269
Operating Profit
(934,523)
458,247
40,599
422,452
Interest Expense
(138,864)
(116,368)
(82,125)
(69,760)
Non-Operating Income
7,446
—
16,166
21,451
Total Non-Operating Income
(131,418)
(116,368)
(65,959)
(48,309)
Income Before Provision for Income Taxes
(1,065,940)
341,879
(25,360)
374,143
Provision for Income Taxes
25,982
77,395
(9,699)
94,110
Consolidated Net Income
(1,091,920)
264,484
(15,661)
280,033
Net Income Attributable to Minority Interests and Other
10,849
8,872
6,006
6,894
Net Income Attributable to Common Shareholders
(1,102,770)
255,612
(21,667)
273,139
Basic EPS
-12.16
2.79
-0.24
3.05
Diluted EPS
-12.16
2.78
-0.24
2.98
Basic Weighted Average Shares Outstanding
90,705
91,621
90,949
89,680
Diluted Weighted Average Shares Outstanding
90,705
92,059
90,949
91,555
Shares Outstanding
90,452
91,775
91,264
89,914
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
133,242
76,305
100,073
97,649
Total Cash and Cash Equivalents
133,242
76,305
100,073
97,649
Accounts Receivable
440,604
365,339
361,451
322,439
Total Trade Receivables
440,604
365,339
361,451
322,439
Other Current Assets
240,293
135,848
134,476
86,037
Total Current Assets
814,139
577,492
596,000
506,125
Net Property, Plant & Equipment
3,245,220
2,971,560
2,384,390
2,087,280
Net Intangible Assets
96,672
70,003
73,278
76,041
Goodwill
—
—
2,225,960
2,222,810
Other Long-Term Assets
75,078
73,007
79,211
95,647
Total Assets
5,527,450
5,956,920
5,358,840
4,987,900
Accounts Payable
150,403
232,704
156,132
104,723
Accrued Expenses
325,193
242,937
674,162
235,890
Current Portion of Long-Term Debt
28,438
76,816
29,219
21,250
Current Portion of Leases
21,160
25,462
26,268
26,463
Total Current Liabilities
525,194
577,919
885,781
388,326
Long-Term Debt
2,471,530
1,880,090
1,342,550
1,364,540
Leases
121,961
101,828
100,808
116,429
Other Long-Term Liabilities
268,212
206,244
142,044
217,621
Total Long-Term Liabilities
2,861,700
2,188,170
1,585,400
1,698,590
Total Liabilities
3,386,900
2,766,080
2,471,180
2,086,920
Common Stock
905
918
913
899
Additional Paid-in Capital
2,713,900
2,685,460
2,649,340
2,658,440
Retained Earnings
(765,841)
387,333
131,721
153,388
Total Common Shareholders' Equity
1,948,960
3,073,720
2,781,970
2,812,730
Minority Interests and Other
191,592
117,116
105,686
88,257
Total Shareholders' Equity
2,140,550
3,190,830
2,887,660
2,900,980
Total Liabilities and Shareholders' Equity
5,527,450
5,956,920
5,358,840
4,987,900
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
(1,091,920)
264,484
(15,661)
280,033
Depreciation & Amortization
189,249
149,595
132,349
117,769
Share-Based Compensation Expense
31,708
37,113
32,289
29,635
Other Adjustments
1,011,530
84,386
306,730
22,486
Changes in Trade Receivables
(75,024)
(2,329)
(39,012)
(41,978)
Changes in Accounts Payable
14,882
(420,893)
17,404
5,174
Changes in Accrued Expenses
26,678
12,115
16,532
6,804
Changes in Other Operating Activities
24,797
5,222
11,709
(39,354)
Cash from Operating Activities
131,898
129,693
462,340
380,569
Capital Expenditure
(571,807)
(690,385)
(424,133)
(296,149)
Proceeds from Sale of Property, Plant & Equipment
23,848
10,435
29,422
7,074
Payments for Business Acquisitions
(8,165)
(53,550)
(349)
(9,507)
Other Investing Activities
(90)
(2,979)
(2,159)
(7,248)
Cash from Investing Activities
(556,214)
(736,479)
(397,219)
(305,830)
Issuance of Short-Term Debt
1,069,000
305,000
40,000
—
Repayments of Short-Term Debt
(1,035,000)
(15,000)
(35,000)
(95,000)
Net Issuance / (Repayments) of Short-Term Debt
34,000
290,000
5,000
(95,000)
Issuance of Long-Term Debt
1,200,000
350,000
—
—
Repayments of Long-Term Debt
(683,044)
(56,331)
(21,250)
(18,594)
Net Issuance / (Repayments) of Long-Term Debt
516,956
293,669
(21,250)
(18,594)
Repurchases of Common Shares
(54,260)
(1,341)
(44,335)
(6,179)
Net Issuance / (Repurchases) of Common Shares
(54,260)
(1,341)
(44,335)
(6,179)
Other Financing Activities
(15,443)
690
(2,112)
8,870
Cash from Financing Activities
481,253
583,018
(62,697)
(110,903)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash